Diaminothiazoles
US7211576B2 · kind B2 · utility
1Cited by
2References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 4, 2005 |
| Grant date | May 1, 2007 |
| Priority date | — |
| Expiry date | Oct 20, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel diaminothiazoles of formula (I):are discussed. These compounds selectively inhibit the activity of Cdk4 and are thus useful in the treatment or control of cancer, in particular, the treatment or control of solid tumors. This invention also provides pharmaceutical compositions containing such compounds and methods of treating or controlling cancer, most particularly, the treatment or control of breast, lung, colon, and prostate tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.